Relationship Between Body Mass Index and High Cystatin Levels Among US Adults

Journal of Clinical Hypertension

Volumn 13, Issue 12, 2011, Pages 925-930

  Shankar, Anoop ^a   Teppala, Srinivas ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CYSTATIN C;

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; DIABETES MELLITUS; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; HYPERTENSION; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RACE; RISK; SMOKING; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BODY MASS INDEX; CHILD; CONFIDENCE INTERVALS; CYSTATIN C; DIABETES MELLITUS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 83055180595     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00548.x     Document Type: Article

References (32)

1. Hojs R, Bevc S, Ekart R, et al. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant. 2006;21:1855-1862.
2. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237-246.
3. Coresh J, Astor B. Decreased kidney function in the elderly: clinical and preclinical, neither benign. Ann Intern Med. 2006;145:299-301.
4. Kestenbaum B, Rudser KD, de Boer IH, et al. Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. Ann Intern Med. 2008;148:501-508.
5. Donahue RP, Stranges S, Rejman K, et al. Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study. Diabetes Care. 2007;30:1724-1729.
6. Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Clin Chem. 2009;55:1932-1943.
7. Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21-28.
8. Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870-1876.
9. Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52:39-48.
10. Wang Y, Chen X, Song Y, et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73:19-33.
11. Shankar A, Leng C, Chia KS, et al. Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore. Nephrol Dial Transplant. 2008;23:1910-1918.
12. National Center for Health Statistics. 1999-2000 National Health and Nutrition Examination Survey: survey operations manuals [article online]. Available at: Accessed March 7, 2011.
13. National Center for Health Statistics. Laboratory procedures used for NHANES 1999-2000]. Available at: Accessed March 7, 2011.
14. National Center for Health Statistics. Laboratory procedures used for NHANES 2000-2002]. Available at: Accessed March 07, 2011.
15. Kottgen A, Selvin E, Stevens LA, et al. Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2008;51:385-394.
16. National Kidney Foundation Kidney Disease Outcomes Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;2(suppl 1):S1-S266.
17. Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766-772.
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
19. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
20. Selvin E, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007;50:918-926.
21. Kyhse-Andersen J, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40:1921-1926.
22. Newman DJ. Cystatin C. Ann Clin Biochem. 2002;39:89-104.
23. Ix JH, Shlipak MG, Chertow GM, et al. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail. 2006;12:601-607.
24. Madero M, Wassel CL, Peralta CA, et al. Cystatin C associates with arterial stiffness in older adults. J Am Soc Nephrol. 2009;20:1086-1093.
25. National Center for Health Statistics. Analytic and reporting guidelines: NHANES III [article online]. Available at: Accessed July 14, 2010.
26. de Jong PE, Verhave JC, Pinto-Sietsma SJ, et al. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002;26(suppl 4):S21-S24.
27. Wu Y, Liu Z, Xiang Z, et al. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147:44-50.
28. Aneja A, El-Atat F, McFarlane SI, et al. Hypertension and obesity. Recent Prog Horm Res. 2004;59:169-205.
29. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911-919.
30. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14:469-477.
31. Naour N, Fellahi S, Renucci JF, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring). 2009;17:2121-2126.
32. Muntner P, Winston J, Uribarri J, et al. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med. 2008;121:341-348.